Soylu, S., Şensoy, N., Doğan, N., Koca, H. B., & Köken, T. (2026). Evaluation of Major Autohemotherapy (MAH) in Psoriasis Patients Using Serum Inflammatory Markers. Journal of Clinical Medicine, 15(2), 485. https://doi.org/10.3390/jcm15020485
Chicago Style (17th ed.) CitationSoylu, Seçil, Nazlı Şensoy, Nurhan Doğan, Halit Buğra Koca, and Tülay Köken. "Evaluation of Major Autohemotherapy (MAH) in Psoriasis Patients Using Serum Inflammatory Markers." Journal of Clinical Medicine 15, no. 2 (2026): 485. https://doi.org/10.3390/jcm15020485.
MLA (9th ed.) CitationSoylu, Seçil, et al. "Evaluation of Major Autohemotherapy (MAH) in Psoriasis Patients Using Serum Inflammatory Markers." Journal of Clinical Medicine, vol. 15, no. 2, 2026, p. 485, https://doi.org/10.3390/jcm15020485.